Alec Machiels, Director at Apellis Pharmaceuticals, Inc. (APLS), sold 1,250 shares at $52.38 ($65K) on 2023-02-17, disclosed to the SEC on 2023-02-21.
Seasonal sale ($65k) by Director — this insider has traded APLS in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| APLS | SELL | 2023-09-19 | $56K | — | Filing → |
| APLS | SELL | 2023-09-18 | $113K | — | Filing → |
| APLS | SELL | 2023-07-18 | $162K | — | Filing → |